Clinical and molecular factors predicting resistance to first-line (1L) FOLFOX in patients (pts) with advanced esophagogastric cancer (EGA) and patterns of subsequent therapy Meeting Abstract


Authors: Greally, M.; Walch, H. S.; Chou, J. F.; Capanu, M.; Kelsen, D. P.; Ilson, D. H.; Janjigian, Y. Y.; Schultz, N.; Ku, G. Y.
Abstract Title: Clinical and molecular factors predicting resistance to first-line (1L) FOLFOX in patients (pts) with advanced esophagogastric cancer (EGA) and patterns of subsequent therapy
Meeting Title: 55th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 37
Issue: 15 Suppl.
Meeting Dates: 2019 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2019-05-20
Start Page: 233s
Language: English
ACCESSION: WOS:000487345805235
DOI: 10.1200/JCO.2019.37.15_suppl.4047
PROVIDER: wos
Notes: Meeting Abstract: 4047 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Joanne Fu-Lou Chou
    331 Chou
  2. Geoffrey Yuyat Ku
    230 Ku
  3. Marinela Capanu
    385 Capanu
  4. Yelena Yuriy Janjigian
    394 Janjigian
  5. David H Ilson
    433 Ilson
  6. David P Kelsen
    537 Kelsen
  7. Nikolaus D Schultz
    486 Schultz
  8. Megan Greally
    30 Greally
  9. Henry Stuart Walch
    100 Walch